McMillan Shakespeare Resultados de beneficios anteriores

Pasado controles de criterios 4/6

McMillan Shakespeare ha aumentado sus beneficios a una tasa media anual de 18.6%, mientras que los beneficios de la industria de Professional Services han experimentado un crecimiento de 3.6% anual. Los ingresos han ido disminuyendo a una tasa media de 3% al año. La rentabilidad financiera de McMillan Shakespeare es de 69.9%, y sus márgenes netos son de 17.3%.

Información clave

18.6%

Tasa de crecimiento de los beneficios

22.4%

Tasa de crecimiento del BPA

Crecimiento de la industria Professional Services	8.7%
Tasa de crecimiento de los ingresos	-3.0%
Rentabilidad financiera	69.9%
Margen neto	17.3%
Última actualización de beneficios	30 Jun 2024

Actualizaciones de resultados anteriores recientes

McMillan Shakespeare (ASX:MMS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Sep 02

Recent updates

The Returns At McMillan Shakespeare (ASX:MMS) Aren't Growing

Sep 17

McMillan Shakespeare (ASX:MMS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Sep 02

McMillan Shakespeare Limited's (ASX:MMS) 26% Price Boost Is Out Of Tune With Earnings

Feb 23

We Ran A Stock Scan For Earnings Growth And McMillan Shakespeare (ASX:MMS) Passed With Ease

Jun 15

McMillan Shakespeare (ASX:MMS) Is Paying Out A Larger Dividend Than Last Year

Mar 06

McMillan Shakespeare (ASX:MMS) Seems To Use Debt Quite Sensibly

Oct 26

Calculating The Intrinsic Value Of McMillan Shakespeare Limited (ASX:MMS)

Aug 31

Is There Now An Opportunity In McMillan Shakespeare Limited (ASX:MMS)?

Jul 28

Is McMillan Shakespeare (ASX:MMS) Using Too Much Debt?

Apr 01

Do These 3 Checks Before Buying McMillan Shakespeare Limited (ASX:MMS) For Its Upcoming Dividend

Mar 06

McMillan Shakespeare (ASX:MMS) Has Compensated Shareholders With A Respectable 60% Return On Their Investment

Feb 09

Do Insiders Own Lots Of Shares In McMillan Shakespeare Limited (ASX:MMS)?

Jan 19

Are Insiders Buying McMillan Shakespeare Limited (ASX:MMS) Stock?

Jan 04

Is McMillan Shakespeare Limited (ASX:MMS) Trading At A 34% Discount?

Dec 20

At AU$11.83, Is McMillan Shakespeare Limited (ASX:MMS) Worth Looking At Closely?

Dec 06

Should We Be Cautious About McMillan Shakespeare Limited's (ASX:MMS) ROE Of 1.0%?

Nov 23

McMillan Shakespeare Limited (ASX:MMS) Insiders Increased Their Holdings

Sep 13

Is Now An Opportune Moment To Examine McMillan Shakespeare Limited (ASX:MMS)?

Aug 25

Desglose de ingresos y gastos

Cómo gana y gasta dinero McMillan Shakespeare. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

ASX:MMS Ingresos, gastos y beneficios (AUD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
30 Jun 24	521	90	251
31 Mar 24	501	83	243
31 Dec 23	481	76	243
30 Sep 23	472	70	249
30 Jun 23	464	64	246
31 Dec 22	347	69	156
30 Sep 22	383	68	188
30 Jun 22	419	67	219
31 Mar 22	601	68	374
31 Dec 21	608	66	380
30 Sep 21	576	63	344
30 Jun 21	544	61	308
31 Mar 21	508	27	278
31 Dec 20	471	-7	248
30 Sep 20	483	-3	261
30 Jun 20	494	1	273
31 Mar 20	520	32	282
31 Dec 19	547	64	290
30 Sep 19	548	64	286
30 Jun 19	550	64	282
31 Mar 19	549	57	279
31 Dec 18	549	49	276
30 Sep 18	547	50	274
30 Jun 18	545	50	272
31 Mar 18	544	56	274
31 Dec 17	542	62	276
30 Sep 17	533	65	272
30 Jun 17	523	68	268
31 Mar 17	518	76	260
31 Dec 16	512	84	253
30 Sep 16	508	83	249
30 Jun 16	505	82	245
31 Mar 16	478	79	224
31 Dec 15	451	75	204
30 Sep 15	420	71	186
30 Jun 15	390	67	167
31 Mar 15	379	67	161
31 Dec 14	369	67	155
30 Sep 14	358	61	151
30 Jun 14	347	55	148
31 Mar 14	339	53	145
31 Dec 13	331	52	142

Ingresos de calidad: MMS tiene un alto nivel de ganancias no monetarias.

Margen de beneficios creciente: Los actuales márgenes de beneficio (17.3%) de MMS son superiores a los del año pasado (13.9%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de MMS han crecido un 18.6% al año en los últimos 5 años.

Acelerando crecimiento: El crecimiento de los beneficios de MMS en el último año (39.7%) supera su media de 5 años (18.6% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de MMS en el último año (39.7%) superó al de la industria Professional Services -10.1%.

Rentabilidad financiera

Alta ROE: Aunque la rentabilidad financiera (69.9%) de MMS es excepcional, esta métrica está sesgada debido a su alto nivel de deuda.

McMillan Shakespeare Resultados de beneficios anteriores

Pasado controles de criterios 4/6

Información clave

Actualizaciones de resultados anteriores recientes

McMillan Shakespeare (ASX:MMS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Full year 2024 earnings: EPS misses analyst expectations

McMillan Shakespeare Limited to Report First Half, 2024 Results on Feb 20, 2024

First half 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

First half 2023 earnings released: EPS: AU$0.48 (vs AU$0.39 in 1H 2022)

Recent updates

The Returns At McMillan Shakespeare (ASX:MMS) Aren't Growing

McMillan Shakespeare Limited Appoints Elizabeth Spooner as Company Secretary

McMillan Shakespeare (ASX:MMS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Full year 2024 earnings: EPS misses analyst expectations

Price target decreased by 7.3% to AU$19.72

Mcmillan Shakespeare Limited Announces Chief Financial Officer Appointments

Upcoming dividend of AU$0.76 per share

First half dividend of AU$0.76 announced

McMillan Shakespeare Limited's (ASX:MMS) 26% Price Boost Is Out Of Tune With Earnings

McMillan Shakespeare Limited to Report First Half, 2024 Results on Feb 20, 2024

Investor sentiment improves as stock rises 22%

Consensus EPS estimates increase by 16%

First half 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 20% undervalued

Price target decreased by 7.3% to AU$18.81

Now 23% undervalued after recent price drop

Now 20% undervalued after recent price drop

When Should You Buy McMillan Shakespeare Limited (ASX:MMS)?

Upcoming dividend of AU$0.66 per share at 7.0% yield

Consensus revenue estimates fall by 15%

Price target increased by 8.6% to AU$18.96

McMillan Shakespeare (ASX:MMS) Has A Pretty Healthy Balance Sheet

Mcmillan Shakespeare Limited Announces Dividend for the Six Month Ended June 30, 2023, Payable on September22, 2023

New major risk - Financial position

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

An unknown buyer acquired Asset Finance Aggregation business of McMillan Shakespeare Limited.

Price target increased by 7.8% to AU$17.45

A Look At The Fair Value Of McMillan Shakespeare Limited (ASX:MMS)

We Ran A Stock Scan For Earnings Growth And McMillan Shakespeare (ASX:MMS) Passed With Ease

McMillan Shakespeare (ASX:MMS) Is Paying Out A Larger Dividend Than Last Year

Upcoming dividend of AU$0.58 per share at 10.0% yield

First half 2023 earnings released: EPS: AU$0.48 (vs AU$0.39 in 1H 2022)

McMillan Shakespeare Limited, Annual General Meeting, Oct 27, 2023

Independent Non-Executive Chairman recently bought AU$62k worth of stock

McMillan Shakespeare (ASX:MMS) Seems To Use Debt Quite Sensibly

Upcoming dividend of AU$0.74 per share

McMillan Shakespeare Limited Appoints Arlene Tansey as Independent Non-Executive Director, Effective 7 November 2022

McMillan Shakespeare Limited Announces Retirement of Tim Poole From the Board of Directors, Effective 31 August 2022

Calculating The Intrinsic Value Of McMillan Shakespeare Limited (ASX:MMS)

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target increased to AU$13.63

McMillan Shakespeare Limited Declares Fully Franked Dividend for the Six Months Ended June 30, 2022, Payable on November 10, 2022

Investor sentiment improved over the past week

Is There Now An Opportunity In McMillan Shakespeare Limited (ASX:MMS)?

Price target decreased to AU$13.01

Price target increased to AU$14.29

Price target decreased to AU$13.23

Upcoming dividend of AU$0.34 per share

McMillan Shakespeare Limited, Annual General Meeting, Oct 28, 2022

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

McMillan Shakespeare Limited Declares an Interim Fully Franked Dividend, Payable on 25 March 2022

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Upcoming dividend of AU$0.31 per share

McMillan Shakespeare Limited (ASX:MMS) acquired Plan Tracker.

Full year 2021 earnings released: EPS AU$0.79 (vs AU$0.016 in FY 2020)

Price target increased to AU$14.84

Independent Non-Executive Director has left the company

Independent Non-Executive Director has left the company

Is McMillan Shakespeare (ASX:MMS) Using Too Much Debt?

Non-Executive Director recently sold AU$1.5m worth of stock

New 90-day low: AU$11.30

Do These 3 Checks Before Buying McMillan Shakespeare Limited (ASX:MMS) For Its Upcoming Dividend

First half 2021 earnings released: EPS AU$0.33 (vs AU$0.42 in 1H 2020)

McMillan Shakespeare Limited (ASX:MMS) acquired remaining 50% stake in Maxxia Limited for AUD 1.8 million.

McMillan Shakespeare (ASX:MMS) Has Compensated Shareholders With A Respectable 60% Return On Their Investment

McMillan Shakespeare Limited to Report Fiscal Year 2021 Results on Aug 24, 2021